Publication Name	World Journal of Gastroenterology
Manuscript ID	20318
Country	Spain

Received	2015-06-01 17:44
Peer-Review Started	2015-06-02 19:29
To Make the First Decision	2015-06-23 15:17
Return for Revision	2015-06-27 17:02
Revised	2015-07-12 19:13
Second Decision	2015-08-19 15:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-02 15:17
Articles in Press	2015-09-02 15:17
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-09-15 00:15
Typeset the Manuscript	2015-10-09 16:19
Publish the Manuscript Online	2015-10-23 15:45

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Current stage in inflammatory bowel disease: What is next?
Manuscript Source	Invited Manuscript
All Author List	Gonzalo Jesús Gómez-Gómez, Ángeles Masedo, Carmen Yela, Maria del Pilar Martínez-Montiel and Begoña Casís
Funding Agency and Grant Number
Corresponding Author	Dr. Maria del Pilar Martínez-Montiel, PhD, Unidad de Enfermedad Inflamatoria Intestinal, Hospital 12 de Octubre, Av\ Córdoba s/n, 28045 Madrid, Spain. pilarmarmon123@telefonica.net
Key Words	Inflammatory bowel disease; Future directions; Pharmacogenetic; Pharmacokinetics; New drugs
Core Tip	The incidence and prevalence of inflammatory bowel disease (IBD) has been increasing worldwide. In recent years, the treatment objectives, the monitoring of IBD, and the drug treatments for controlling the disorder have been evolving. This review summarizes recent developments in pharmacogenetics, clinical pharmacology, and the use of new drug molecules that may expand IBD treatment options in the future.
Publish Date	2015-10-23 15:45
Citation	Gómez-Gómez GJ, Masedo Á, Yela C, Martínez-Montiel MP, Casís B. Current stage in inflammatory bowel disease: What is next? World J Gastroenterol 2015; 21(40): 11282-11303
URL	http://www.wjgnet.com/1007-9327/full/v21/i40/11282.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i40.11282

Full Article (PDF)	WJG-21-11282.pdf
Full Article (Word)	WJG-21-11282.doc
Manuscript File	20318-Review.docx
Answering Reviewers	20318-Answering reviewers.pdf
Audio Core Tip	20318-Audio core tip.wav
Copyright License Agreement	20318-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	20318-Language certificate.pdf
Peer-review Report	20318-Peer-review(s).pdf
Scientific Misconduct Check	20318-Scientific misconduct check.pdf
Scientific Editor Work List	20318-Scientific editor work list.pdf